Decision ownership
Escalations move between the sponsor and CRO without a named approver or decision date.
Lampgen Advisory · Clinical operations consulting
When a decision keeps moving between the sponsor, CRO, and study team, Lampgen Advisory helps identify where execution is breaking down, who should own the next decision, and how to check that the action worked.
FIRST PAID ENGAGEMENT
Scope the diagnostic to one study and one decision. We examine the milestone, relevant issue records, decision authority, and handoffs. You receive a short evidence summary, a recommended action, a proposed decision owner, and one measure of follow-through.
We agree on scope and fee after the briefing. If you need help implementing the recommendation, we scope that work separately and agree on how to review progress with your team.
Escalations move between the sponsor and CRO without a named approver or decision date.
Site activation, cohort expansion, or database lock depends on handoffs across teams.
Corrective actions are recorded, and your team needs a clearer way to check whether the issue recurs.
FOR ONCOLOGY SPONSORS
Tommy Lampley Jr., Founder of Lampgen Clinical Research, leads the briefing. Bring one upcoming milestone and the decision your team is working through.
For ongoing review with an existing team, explore SIGNAL Managed Monitoring. For a defined role, request oncology staffing.